ASGE Annual GI Advanced Practice Provider Course (Virtual) - Clinical Case-Based Learning (Day Two) | April 2023-Questions and Answers: Session 6

Video Transcription

Video Summary

In this video, a panel of experts addresses questions related to the management of small intestinal bacterial overgrowth (SIBO). The panelists discuss the challenges of obtaining coverage for the antibiotic rifaximin, which is commonly used to treat SIBO but may not be covered by insurance. They also explore alternatives such as neomycin and metronidazole. The panelists emphasize the importance of ruling out other conditions and considering the individual patient's symptoms before focusing on SIBO treatment. They also mention the use of herbal products as a potential option. In addition to SIBO, the panel discusses topics related to celiac disease, such as serology testing and surveillance for Barrett's esophagus and gastric intestinal metaplasia. They provide insights on proper management and address concerns about the long-term use of proton pump inhibitors (PPIs). Overall, the panel provides practical recommendations and insights based on current guidelines and evidence. No credits were mentioned in the video.

Keywords

SIBO management

rifaximin coverage

alternative treatments

celiac disease

proton pump inhibitors